086460 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Curable, Inc. engages in the provision of genome analytics services. Its services include genetic analysis, genetic diagnosis, and development of single nucleotide polymorphism analysis busine diagnostic marker. The company was founded on May 26, 2000 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
086460 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company